KSI kneat.com inc

ALTEN Selects Kneat to Digitize Validation

ALTEN Selects Kneat to Digitize Validation

LIMERICK, Ireland, Nov. 27, 2024 (GLOBE NEWSWIRE) -- kneat.com, inc. (TSX: KSI) (OTCQX: KSIOF), a leader in digitizing and automating validation and quality processes, is pleased to announce that it has signed a three-year Master Services Agreement with ALTEN SA, a world leader in Engineering and IT Services. ALTEN will leverage Kneat Gx to digitize its own validation processes and those of its customers within the Life Sciences space.

With almost 60,000 employees and operations in more than 30 countries worldwide, ALTEN’s services support companies’ innovation, R&D, and technological information systems efforts. ALTEN’s customers in the Life Sciences & Health industries operate in pharmaceuticals, biotechnology, medical devices, biomedical technologies, nutrition, cosmetics, food processing, and other areas dedicated to improving lives. ALTEN plans to use Kneat Gx for its own projects, and to enable the use of Kneat Gx by its customers, starting with Commissioning and Qualification.

“Our partnership with ALTEN is excellent news for validation across the Life Sciences ecosystem,” stated Eddie Ryan, co-founder and CEO of Kneat. “By digitizing their validation workflows on Kneat Gx, both ALTEN and their customers will enjoy significant collaboration, time and cost benefits.”

“We are excited to begin this partnership, as digital validation represents a significant step towards transforming the industry by ensuring improved efficiency, data integrity, and the delivery of safe, high-quality solutions for patients,” said Quentin Birot, Director, Life Sciences Manufacturing & Clinical Operations in Europe at ALTEN.

About ALTEN

Created in 1988, ALTEN supports its customers’ development strategies in the areas of innovation, R&D and technological information systems.

ALTEN works with key actors in the Aeronautics, Space, Defence, Security & Naval, Automotive, Rail & Mobility, Energy & Environment, Life Sciences & Health, Industrial Equipment & Electronics, Telecoms, Banking, Finance & Insurance, Retail, Services & Media, Public Services & Government sectors.

The Group has a workforce of 58,300 employees operating in 30+ countries, 88% of whom are engineers. Its 2023 turnover was €4,07 billion.

ALTEN’s stock is listed in compartment A of the Euronext Paris market (ISIN FR000001946); it is part of the SBF 120, the IT CAC 50 index and MIDCAP100, and is eligible for the deferred Settlement Service (SRD).

About Kneat

Kneat Solutions provides leading companies in highly regulated industries with unparalleled efficiency in validation and compliance through its digital validation platform Kneat Gx. We lead the industry in customer satisfaction with an unblemished record for implementation, powered by our user-friendly design, expert support, and on-demand training academy. Kneat Gx is an industry-leading digital validation platform that enables highly regulated companies to manage any validation discipline from end-to-end. Kneat Gx is fully ISO 9001 and ISO 27001 certified, fully validated, and 21 CFR Part 11/Annex 11 compliant. Multiple independent customer studies show up to 40% reduction in documentation cycle times, up to 20% faster speed to market, and a higher compliance standard.

Cautionary and Forward-Looking Statements

Except for the statements of historical fact contained herein, certain information presented constitutes “forward-looking information” within the meaning of applicable Canadian securities laws. Such forward-looking information includes, but is not limited to, the relationship between Kneat and the customer, Kneat’s business development activities, the use and implementation timelines of Kneat’s software within the customer’s validation processes, the ability and intent of the customer to scale the use of Kneat’s software within the customer’s organization and the compliance of Kneat’s platform under regulatory audit and inspection. While such forward-looking statements are expressed by Kneat, as stated in this release, in good faith and believed by Kneat to have a reasonable basis, they are subject to important risks and uncertainties. As a result of these risks and uncertainties, the events predicted in these forward-looking statements may differ materially from actual results or events. These forward-looking statements are not guarantees of future performance, given that they involve risks and uncertainties.

Kneat does not undertake any obligation to release publicly revisions to any forward-looking statement, except as may be required under applicable securities laws. Investors should not assume that any lack of update to a previously issued forward-looking statement constitutes a reaffirmation of that statement. Continued reliance on forward-looking statements is at an investor’s own risk.

For further information:

Kneat Investor Relations

 

Alten Public Relations



EN
27/11/2024

Underlying

To request access to management, click here to engage with our
partner Phoenix-IR's CorporateAccessNetwork.com

Reports on kneat.com inc

 PRESS RELEASE

Kneat Announces Upcoming Change to its Senior Leadership

Kneat Announces Upcoming Change to its Senior Leadership LIMERICK, Ireland, June 30, 2025 (GLOBE NEWSWIRE) -- kneat.com, inc. (TSX: KSI) (OTCQC: KSIOF), a leader in digitizing and automating validation and quality processes, announces a change to its senior leadership team. Hugh Kavanagh, our CFO, is retiring from Kneat to spend more time pursuing other interests. We wish him the very best for the future. During his time at Kneat, Hugh contributed significantly to our success, helping the Company to grow to its current level and building a strong finance team. We have very much enjoyed w...

 PRESS RELEASE

Global Healthcare Technology Leader Selects Kneat

Global Healthcare Technology Leader Selects Kneat LIMERICK, Ireland, June 26, 2025 (GLOBE NEWSWIRE) -- kneat.com, inc. (TSX: KSI) (OTCQC: KSIOF), a leader in digitizing and automating validation and quality processes, is pleased to announce that a leading healthcare technology and diagnostics company (“the Company”) has signed a multi-year Master Services Agreement with Kneat. The Company, which is headquartered in the United States, employs over 50,000 people and manufactures in more than a dozen countries worldwide. This manufacturer of medical technology, including medical devices and...

 PRESS RELEASE

Kneat Announces Results of Voting at Annual General Meeting

Kneat Announces Results of Voting at Annual General Meeting LIMERICK, Ireland, May 28, 2025 (GLOBE NEWSWIRE) -- kneat.com, inc. (TSX: KSI) (OTC: KSIOF) ("Kneat" or the "Company") a leader in digitizing and automating validation processes, announced results from its Annual General Meeting of Shareholders (the "2025 AGM"), which took place today. All director nominees were elected to the board of directors (the "Kneat Board") and KPMG LLP was appointed as auditors, as further described in the related Management Information Circular dated April 23, 2025 (the "Circular"). The detailed result...

 PRESS RELEASE

Global Diagnostics Leader Selects Kneat

Global Diagnostics Leader Selects Kneat LIMERICK, Ireland, May 15, 2025 (GLOBE NEWSWIRE) -- kneat.com, inc. (TSX: KSI) (OTCQC: KSIOF), a leader in digitizing and automating validation and quality processes, is pleased to announce that a manufacturer of clinical diagnostics for the healthcare industry (“the Company”) has signed a three-year Master Services Agreement with Kneat. The Company, which is headquartered in the United States, operates in more than 40 countries and employs over 14,000 people, provides a comprehensive range of clinical diagnostics and biomedical testing for the hea...

 PRESS RELEASE

Kneat Announces Record Revenue for First Quarter 2025

Kneat Announces Record Revenue for First Quarter 2025 LIMERICK, Ireland, May 07, 2025 (GLOBE NEWSWIRE) -- kneat.com, inc. (TSX: KSI) (OTC: KSIOF) (“Kneat” or the “Company”) a leader in digitizing and automating validation and quality processes, today announced financial results for the three months ended March 31, 2025. All dollar amounts are presented in Canadian dollars unless otherwise stated. Total revenue reaches $14.7 million in the first quarter, an increase of 37% year over yearAnnual Recurring Revenue (ARR)1 at March 31, 2025, reaches $63.5 million, an increase of 51% year over ...

ResearchPool Subscriptions

Get the most out of your insights

Get in touch